Multi-Level High-Throughput Screening for Discovery of Ligands That Inhibit Insulin Aggregation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multi-Level High-Throughput Screening for Discovery of Ligands That Inhibit Insulin Aggregation

Published:2022-09-29 Issue:11 Volume:19 Page:3770-3783
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Mishra Rit Pratik¹^ORCID,Gupta Surbhi¹,Rathore Anurag Singh¹^ORCID,Goel Gaurav¹^ORCID

Affiliation:

1. Department of Chemical Engineering, Indian Institute Technology Delhi, New Delhi, 110016, India

Funder

Science and Engineering Research Board

Ministry of Human Resource Development

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.2c00219

Reference133 articles.

1. Identification and validation of signal recognition particle 14 as a prognostic biomarker predicting overall survival in patients with acute myeloid leukemia

2. Benchmarking Sets for Molecular Docking

3. A kinase inhibitor screen identifies signaling pathways regulating mucosal growth during otitis media

4. The specificities of protein kinase inhibitors: an update

5. Successful Virtual Screening of a Chemical Database for Farnesyltransferase Inhibitor Leads

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stability of Protein Pharmaceuticals: Recent Advances;Pharmaceutical Research;2024-06-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP